Institutional Fund
5am Venture Management, LLC
San Francisco, CACIK 17998835 filings on record
Portfolio Value
$360.21M
Q1 2026
Holdings
20
Reported positions
New Buys
2
Opened this quarter
QoQ Change
+13.2%
from $318.10M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Erasca Inc15.7%
- Entrada Therapeutics Inc14.2%
- Tyra Biosciences Inc10.9%
- Camp4 Therapeutics Corp7.2%
- Centessa Pharmaceuticals PLC6.4%
- Pharvaris N V6.3%
- Other39.3%
Portfolio Holdings
20 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Erasca Inc | 3.49M | $56.40M | 15.7% | −1.92M | Reduced |
| 2 | Entrada Therapeutics Inc | 4.06M | $51.19M | 14.2% | 0 | Held |
| 3 | Tyra Biosciences Inc | 1.03M | $39.42M | 10.9% | 0 | Held |
| 4 | Camp4 Therapeutics Corp | 5.87M | $25.88M | 7.2% | 0 | Held |
| 5 | Centessa Pharmaceuticals PLC | 580.9K | $23.08M | 6.4% | 0 | Held |
| 6 | Pharvaris N V | 797.6K | $22.53M | 6.3% | 0 | Held |
| 7 | Maplight Therapeutics Inc | 950.0K | $19.31M | 5.4% | 0 | Held |
| 8 | Tectonic Therapeutic Inc | 606.7K | $18.75M | 5.2% | 0 | Held |
| 9 | Celldex Therapeutics Inc New | 497.3K | $15.77M | 4.4% | 0 | Held |
| 10 | Artiva Biotherapeutics Inc | 2.35M | $15.16M | 4.2% | 0 | Held |
10 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio